Home
Journal Club
Explore
More
Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Language
English
English
GM
Gideon M. Hirschfield
Liver Diseases and Immunity
University Health Network
Share
Follow
Claim This Profile
About
Research focus
Liver Diseases and Immunity
Impact
763 pubs · 43,130 cites · h-index 95
Affiliations
University Health Network
University of Toronto
Toronto General Hospital
See all
Publications
Recent publications by Gideon M. Hirschfield
Autoimmune hepatitis: special groups and treatment gaps
JHEP Reports · Tue,
Improving the quality of paracentesis practices in people with advanced cirrhosis in an ambulatory care setting
Journal of the Canadian Association of Gastroenterology · Tue,
Living liver donor safety: Intraoperative considerations in living liver donation—Guidelines from the ILTS–iLDLT group consensus conference 2025
Liver Transplantation · Mon,
Long-term considerations following living liver donation—Guidelines from the 2025 ILTS-iLDLT consensus conference on living liver donor safety
Liver Transplantation · Thu,
Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort study
BMJ Open Gastroenterology · Mon,
Clinicogenomic Characterization of Primary Sclerosing Cholangitis–Associated Biliary Tract Cancers
Clinical Cancer Research · Tue,
Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis
Journal of Hepatology · Fri,
High biochemical remission rates in patients with primary biliary cholangitis treated with “triple” anticholestatic therapy
Hepatology Communications · Mon,
Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitis
Journal of Hepatology · Sat,
Long-term efficacy and safety of open-label seladelpar treatment in patients with primary biliary cholangitis: pooled interim results for up to 3 years from the ASSURE study
Zeitschrift für Gastroenterologie · Mon,